• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    NPS Pharmaceuticals, Inc. (NPSP)

    -NasdaqGS
    45.86 Down 0.05(0.11%) Jan 30, 3:59PM EST
    Add to Portfolio
    Prev Close:45.91
    Open:45.85
    Bid:N/A
    Ask:45.89 x 500
    1y Target Est:44.00
    Beta:0.1
    Earnings Date:Feb 16 - Feb 20 (Est.)
    Day's Range:45.84 - 45.90
    52wk Range:22.11 - 46.01
    Volume:3,854,539
    Avg Vol (3m):3,850,330
    Market Cap:4.90B
    P/E (ttm):4,586.00
    EPS (ttm):0.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NPSP

    Comparison

    Symbol% ChgMkt Cap
    NPSPDown 0.11%4.90B
    ABTDown 1.10%67.40B
    BIIBUp 10.17%91.64B

    Key Statistics

    Forward P/E (1 yr):65.51
    P/S (ttm):23.16
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.01
    Quarterly EPS Est (Dec-14) :0.05
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-42.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback